Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
orfadin nitisinoni
orfadin nitisinone
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vaikuttava aine on nitisinoni.
the active substance is nitisinone.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
orfadinin vaikuttava aine on nitisinoni.
the active ingredient of orfadin is nitisinone.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
orfadin 4 mg/ml oraalisuspensio nitisinoni
orfadin 4 mg/ml oral suspension nitisinone
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
orfadin 2 mg kovat kapselit nitisinoni
orfadin 2 mg hard capsules nitisinone
Last Update: 2012-04-10
Usage Frequency: 9
Quality:
ei tiedetä, erittyykö nitisinoni ihmisen rintamaitoon.
it is unknown whether nitisinone is excreted in human breast milk.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
orfadin 5 mg kovat kapselit nitisinoni suun kautta
orfadin 5 mg hard capsules nitisinone oral use
Last Update: 2012-04-10
Usage Frequency: 8
Quality:
orfadin on lääke, jonka vaikuttava aine on nitisinoni.
orfadin is a medicine that contains the active substance nitisinone.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vaikutustapansa perusteella nitisinoni suurentaa tyrosiinipitoisuuksia kaikilla nitisinonihoitoa saavilla potilailla.
by its mode of action, nitisinone increases tyrosine levels in all nitisinone treated patients.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
orfadinin vaikuttava aine nitisinoni salpaa entsyymin, joka muuntaa tyrosiinia haitallisiksi aineiksi.
the active substance in orfadin, nitisinone, blocks an enzyme that converts tyrosine into harmful substances.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
nitisinoni on 4-hydroksifenyylipyruvaattidioksigenaasin kilpaileva estäjä.tämä entsyymi edeltää fumaryyliasetoasetaattihydrolaasia tyrosiinikataboliareitissä.
nitisinone is a competitive inhibitor of 4-hydroxyphenylpyruvate dioxygenase, an enzyme which precedes fumarylacetoacetate hydrolase in the tyrosine catabolic pathway.
Last Update: 2008-03-04
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
orfadin 2 mg kovat kapselit orfadin 5 mg kovat kapselit orfadin 10 mg kovat kapselit nitisinoni
information for the userorfadin 2 mg hard capsules orfadin 5 mg hard capsules orfadin 10 mg hard capsules nitisinone
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
orfadin 2 mg kovat kapselit orfadin 5 mg kovat kapselit orfadin 10 mg kovat kapselit orfadin 20 mg kovat kapselit nitisinoni
orfadin 2 mg hard capsules orfadin 5 mg hard capsules orfadin 10 mg hard capsules orfadin 20 mg hard capsules nitisinone
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
estämällä tyrosiinin normaalia kataboliaa ht-1-potilailla nitisinoni estää myrkyllisten välituotteiden eli maleyyliasetoasetaatin ja fumaryyliasetoasetaatin kumulaatiota.
by inhibiting the normal catabolism of tyrosine in patients with ht-1, nitisinone prevents the accumulation of the toxic intermediates maleylacetoacetate and fumarylacetoacetate.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
estämällä tyrosiinin normaalia kataboliaa ht- 1- potilailla nitisinoni estää samalla myös myrkyllisten väliaineiden eli maleyyliasetoasetaatin ja fumaryyliasetoasetaatin kertymistä.
by inhibiting the normal catabolism of tyrosine in patients with ht-1, nitisinone prevents the accumulation of the toxic intermediates maleylacetoacetate and fumarylacetoacetate.
Last Update: 2012-04-10
Usage Frequency: 5
Quality:
nitisinoni metaboloituu in vitro cyp 3a4: n kautta.tästä syystä annosta voidaan joutua säätämään, kun nitisinonia annetaan samaan aikaan tämän entsyymin estäjien tai indusoijien kanssa.
nitisinone is metabolised in vitro by cyp 3a4 and dose-adjustment may therefore be needed when nitisinone is co-administered with inhibitors or inducers of this enzyme.
Last Update: 2008-03-04
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
kaneilla nitisinoni aiheutti annokseen liittyvää epämuodostumien yleistymistä (napatyrä ja vatsahalkio), kun annostaso oli vähintään 2, 5- kertainen verrattuna ihmisen suurimpaan suositeltuun annokseen (2 mg/ kg/ vrk).
in the rabbit, nitisinone induced a dose-related increase in malformations (umbilical hernia and gastroschisis) from a dose level of 2.5-fold higher than the maximum recommended human dose (2 mg/ kg/ day).
Last Update: 2012-04-10
Usage Frequency: 5
Quality: